255 related articles for article (PubMed ID: 34425107)
21. Sulforaphane down-regulates SKP2 to stabilize p27(KIP1) for inducing antiproliferation in human colon adenocarcinoma cells.
Chung YK; Chi-Hung Or R; Lu CH; Ouyang WT; Yang SY; Chang CC
J Biosci Bioeng; 2015 Jan; 119(1):35-42. PubMed ID: 25070589
[TBL] [Abstract][Full Text] [Related]
22. Specific small molecule inhibitors of Skp2-mediated p27 degradation.
Wu L; Grigoryan AV; Li Y; Hao B; Pagano M; Cardozo TJ
Chem Biol; 2012 Dec; 19(12):1515-24. PubMed ID: 23261596
[TBL] [Abstract][Full Text] [Related]
23. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.
Calvisi DF; Ladu S; Pinna F; Frau M; Tomasi ML; Sini M; Simile MM; Bonelli P; Muroni MR; Seddaiu MA; Lim DS; Feo F; Pascale RM
Gastroenterology; 2009 Nov; 137(5):1816-26.e1-10. PubMed ID: 19686743
[TBL] [Abstract][Full Text] [Related]
24. Early mitotic inhibitor-1, an anaphase-promoting complex/cyclosome inhibitor, can control tumor cell proliferation in hepatocellular carcinoma: correlation with Skp2 stability and degradation of p27(Kip1).
Zhao Y; Tang Q; Ni R; Huang X; Wang Y; Lu C; Shen A; Wang Y; Li C; Yuan Q; Chen H; Cheng C; He S
Hum Pathol; 2013 Mar; 44(3):365-73. PubMed ID: 22995332
[TBL] [Abstract][Full Text] [Related]
25. Quinacrine upregulates p21/p27 independent of p53 through autophagy-mediated downregulation of p62-Skp2 axis in ovarian cancer.
Jung D; Khurana A; Roy D; Kalogera E; Bakkum-Gamez J; Chien J; Shridhar V
Sci Rep; 2018 Feb; 8(1):2487. PubMed ID: 29410485
[TBL] [Abstract][Full Text] [Related]
26. NDRG2 facilitates colorectal cancer differentiation through the regulation of Skp2-p21/p27 axis.
Shen L; Qu X; Li H; Xu C; Wei M; Wang Q; Ru Y; Liu B; Xu Y; Li K; Hu J; Wang L; Ma Y; Li M; Lai X; Gao L; Wu K; Yao L; Zheng J; Zhang J
Oncogene; 2018 Mar; 37(13):1759-1774. PubMed ID: 29343851
[TBL] [Abstract][Full Text] [Related]
27. Targeting the oncogenic E3 ligase Skp2 in prostate and breast cancer cells with a novel energy restriction-mimetic agent.
Wei S; Chu PC; Chuang HC; Hung WC; Kulp SK; Chen CS
PLoS One; 2012; 7(10):e47298. PubMed ID: 23071779
[TBL] [Abstract][Full Text] [Related]
28. Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence.
Lin HK; Chen Z; Wang G; Nardella C; Lee SW; Chan CH; Yang WL; Wang J; Egia A; Nakayama KI; Cordon-Cardo C; Teruya-Feldstein J; Pandolfi PP
Nature; 2010 Mar; 464(7287):374-9. PubMed ID: 20237562
[TBL] [Abstract][Full Text] [Related]
29. Tuberin binds p27 and negatively regulates its interaction with the SCF component Skp2.
Rosner M; Hengstschläger M
J Biol Chem; 2004 Nov; 279(47):48707-15. PubMed ID: 15355997
[TBL] [Abstract][Full Text] [Related]
30. Silencing of KIF14 interferes with cell cycle progression and cytokinesis by blocking the p27(Kip1) ubiquitination pathway in hepatocellular carcinoma.
Xu H; Choe C; Shin SH; Park SW; Kim HS; Jung SH; Yim SH; Kim TM; Chung YJ
Exp Mol Med; 2014 May; 46(5):e97. PubMed ID: 24854087
[TBL] [Abstract][Full Text] [Related]
31. Activation of ubiquitin ligase SCF(Skp2) by Cks1: insights from hydrogen exchange mass spectrometry.
Yao ZP; Zhou M; Kelly SE; Seeliger MA; Robinson CV; Itzhaki LS
J Mol Biol; 2006 Oct; 363(3):673-86. PubMed ID: 16979657
[TBL] [Abstract][Full Text] [Related]
32. The G1 phase E3 ubiquitin ligase TRUSS that gets deregulated in human cancers is a novel substrate of the S-phase E3 ubiquitin ligase Skp2.
Jamal A; Swarnalatha M; Sultana S; Joshi P; Panda SK; Kumar V
Cell Cycle; 2015; 14(16):2688-700. PubMed ID: 26038816
[TBL] [Abstract][Full Text] [Related]
33. Skp2-mediated p27(Kip1) degradation during S/G2 phase progression of adipocyte hyperplasia.
Auld CA; Fernandes KM; Morrison RF
J Cell Physiol; 2007 Apr; 211(1):101-11. PubMed ID: 17096381
[TBL] [Abstract][Full Text] [Related]
34. Ubiquitination of p27Kip1 requires physical interaction with cyclin E and probable phosphate recognition by SKP2.
Ungermannova D; Gao Y; Liu X
J Biol Chem; 2005 Aug; 280(34):30301-9. PubMed ID: 15980415
[TBL] [Abstract][Full Text] [Related]
35. Targeting the p27 E3 ligase SCF(Skp2) results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy.
Chen Q; Xie W; Kuhn DJ; Voorhees PM; Lopez-Girona A; Mendy D; Corral LG; Krenitsky VP; Xu W; Moutouh-de Parseval L; Webb DR; Mercurio F; Nakayama KI; Nakayama K; Orlowski RZ
Blood; 2008 May; 111(9):4690-9. PubMed ID: 18305219
[TBL] [Abstract][Full Text] [Related]
36. The tumor suppressor ING3 is degraded by SCF(Skp2)-mediated ubiquitin-proteasome system.
Chen G; Wang Y; Garate M; Zhou J; Li G
Oncogene; 2010 Mar; 29(10):1498-508. PubMed ID: 19935701
[TBL] [Abstract][Full Text] [Related]
37. Degradation of Tob1 mediated by SCFSkp2-dependent ubiquitination.
Hiramatsu Y; Kitagawa K; Suzuki T; Uchida C; Hattori T; Kikuchi H; Oda T; Hatakeyama S; Nakayama KI; Yamamoto T; Konno H; Kitagawa M
Cancer Res; 2006 Sep; 66(17):8477-83. PubMed ID: 16951159
[TBL] [Abstract][Full Text] [Related]
38. The interaction of SKP2 with p27 enhances the progression and stemness of osteosarcoma.
Wang J; Aldahamsheh O; Ferrena A; Borjihan H; Singla A; Yaguare S; Singh S; Viscarret V; Tingling J; Zi X; Lo Y; Gorlick R; Zheng D; Schwartz EL; Zhao H; Yang R; Geller DS; Hoang BH
Ann N Y Acad Sci; 2021 Apr; 1490(1):90-104. PubMed ID: 33594717
[TBL] [Abstract][Full Text] [Related]
39. Oncostatin M induces growth arrest by inhibition of Skp2, Cks1, and cyclin A expression and induced p21 expression.
Halfter H; Friedrich M; Resch A; Kullmann M; Stögbauer F; Ringelstein EB; Hengst L
Cancer Res; 2006 Jul; 66(13):6530-9. PubMed ID: 16818624
[TBL] [Abstract][Full Text] [Related]
40. Skp2 inversely correlates with p27 and tuberin in transformed cells.
Rosner M; Hanneder M; Siegel N; Valli A; Fuchs C; Hengstschläger M
Amino Acids; 2009 Jul; 37(2):257-62. PubMed ID: 18604603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]